Replies to post #25603 on Biotech Values

[DewDiligence]

>anybody here listen to the DNDN CC, i wasn't able to and would love a summary<

1. Repetition of the prior guidance about the timing of the BLA submission and manufacturing buildout.

2. Softball questions from Mark Monane that sounded even more scripted than they usually do.